Gunnar Fernström

Stayble is a clinical stage pharmaceutical company developing the injection treatment STA363 for disc-related chronic low back pain. The treatment is aimed at patients whose back pain persists after physiotherapy and painkillers. The injection is given once and the effect is expected to remain throughout the entirety of the patient’s life and requires minimal rehabilitation. The Company’s focus is set upon the continued clinical development of the upcoming phase 2b study. Stayble’s vision is to develop STA363 as a new standard treatment for patients suffering from chronic disc-related low back pain.

21grams offers postal management to corporate customers by leveraging its technology leadership in postage optimisation, in combination with its unique set of knowledge and experience of post, print and document management software. The Company’s offering allows customers to outsource their non-core production of bulk mailings, simplify their communication processes and to significantly reduce postage expenses by exploiting savings opportunities on deregulated postage markets.

Besedo is a leading provider of products and services for content security and moderation, to online marketplaces. Since the start in 2002, Besedo has specialized in defeating fraud by constantly analyzing patterns and trends to stay ahead of scammers. Customers are benefitting from improved content quality and relevancy, enabling them to deliver better experiences to their users. Besedo today offers a mix of automation with the newly released tool Implio, and manual moderation by teams in five offices around the world, all tailor made to the needs of its clients.

Medius links invoice capture, processing, and payment to replace the worry and wondering of managing AP with calm and confidence. Medius goes far beyond basic automation by using artificial intelligence to do most of the work – so invoices get coded, approved and paid; customers get to go home and rest easy; and businesses can trust budgets and forecasts. For more information, please visit medius.com.

Stayble is a clinical stage pharmaceutical company developing the injection treatment STA363 for disc-related chronic low back pain. The treatment is aimed at patients whose back pain persists after physiotherapy and painkillers. The injection is given once and the effect is expected to remain throughout the entirety of the patient’s life and requires minimal rehabilitation. The Company’s focus is set upon the continued clinical development of the upcoming phase 2b study. Stayble’s vision is to develop STA363 as a new standard treatment for patients suffering from chronic disc-related low back pain.

Chalmers Ventures is a leading Tech Investor and Venture Builder in the Nordics, dedicated to creating global growth companies and taking new technology from lab to market. Focus is on university spin-outs and deep tech. We employ a unique dual approach that integrates venture creation with tech investments, harnessing the potential of new research and deep tech within Chalmers. Our expertise lies in initiating and nurturing companies from groundbreaking research, ensuring a robust pipeline of high-quality ventures in which we invest and act as active owners. Our involvement extends through the entire company lifecycle until exit, with the aim to generate substantial business success and make a positive global impact.

A recognized leader in the field of expanded bed chromatography (EBA), Upfront is a Danish company providing biomolecule (proteins & oligosaccharides) isolation and separation technology to the food & feed, industrial enzymes and life science sectors. Currently focusing on the dairy industry, Upfront is designing and implementing disruptive dairy solutions that enable dairies to benefit from businesses utilizing dairy ingredient products requiring high levels of purity and retaining native functionalities. By enabling high volume production of these types of products and enhancing the valorisation of diverse feed-streams, Upfront strives to deliver value to the customer's bottom line. In addition to the dairy industry, EBA is well suited to extracting high value products from a variety of feed and waste streams in the sectors noted above. The opportunities for new business models that impart added value to existing operations depend upon specific product requirements and existing or planned configurations. Upfront encourages an open dialogue to create dedicated solutions tailored to your needs.

21grams offers postal management to corporate customers by leveraging its technology leadership in postage optimisation, in combination with its unique set of knowledge and experience of post, print and document management software. The Company’s offering allows customers to outsource their non-core production of bulk mailings, simplify their communication processes and to significantly reduce postage expenses by exploiting savings opportunities on deregulated postage markets.